Synergistic antifungal interactions of amphotericin B with 4-(5-methyl-1,3,4-thiadiazole-2-yl) benzene-1,3-diol

Amphotericin B (AmB) is a very potent antifungal drug with very rare resistance among clinical isolates. Treatment with the AmB formulations available currently is associated with severe side effects. A promising strategy to minimize the toxicity of AmB is reducing its dose by combination therapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chudzik, Barbara, Bonio, Katarzyna, Dabrowski, Wojciech, Pietrzak, Daniel, Niewiadomy, Andrzej, Olender, Alina, Malodobry, Katarzyna, Gagoś, Mariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737028/
https://www.ncbi.nlm.nih.gov/pubmed/31506532
http://dx.doi.org/10.1038/s41598-019-49425-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737028/
https://www.ncbi.nlm.nih.gov/pubmed/31506532
http://dx.doi.org/10.1038/s41598-019-49425-1

Ejemplares similares